相关实验视频
Updated: Jul 7, 2025

07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
24.7K
在患有结核性硬化综合体的儿童中,长期使用everolimus治疗耐火性心律失常
Christoph Hofmann1,2, Steffen Syrbe3, Joachim Hebe4
1Department of Internal Medicine III (Cardiology, Angiology, and Pneumology), Heidelberg University Hospital, Heidelberg, Germany.
American journal of medical genetics. Part A
|December 22, 2023
概括
与结核性硬化综合体 (TSC) 相关的导致严重心律失常的心脏狂肌瘤已成功用mTOR抑制剂everolimus治疗. 长期治疗控制了心律失常,以后的切除消除了残留事件.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 结核性硬化综合体 (TSC) 经常导致心脏狂宫肌瘤.
- 这些瘤可能导致危及生命的心律失常,对传统治疗无反应.
相关概念视频
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.0K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.0K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K

